Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-ascending-dose study of MEDI0382 in overweight and obese subjects with type 2 diabetes mellitus
2014-003716-36Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM), Overweight and obesity comparing MEDI0382 arm with Placebo arm (2 arms). Primary endpoint: Effect of MEDI0382 on glucose control and body weight. Started Dec 2014; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)Overweightobesity
Beyond the preview
Go deeper on 2014-003716-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003716-36.